# TD-6450 SAD and MAD in Healthy Subjects

> **NCT02022306** · PHASE1 · COMPLETED · sponsor: **Theravance Biopharma** · enrollment: 111 (actual)

## Conditions studied

- Hepatitis C

## Interventions

- **DRUG:** TD-6450
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02022306
- **Lead sponsor:** Theravance Biopharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-02
- **Primary completion:** 2014-08
- **Final completion:** 2014-09
- **Target enrollment:** 111 (ACTUAL)
- **Last updated:** 2021-01-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02022306

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02022306, "TD-6450 SAD and MAD in Healthy Subjects". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02022306. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*